Company / Operating Margin
VitaNova Life Sciences Corp Operating Margin History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
45.4%
FY2024
5-year range
-63.8% / 45.4%
FY2021-FY2024
Trend
+26.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -63.8% to 45.4% over the past 2 years.
Based on SEC 10-K filings.
45.4% in FY2024 with a 3-year CAGR of +56.5%.
Improved from -63.8% to 45.4% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +56.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin increased 26.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 45.4% | +26.0% |
| FY2023 | 36.0% | +156.5% |
| FY2022 | -63.8% | -472.4% |
| FY2021 | -11.1% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026